Is continuous ketone monitoring on the horizon for Aussies?
Diabetes experts in Australia are advocating for continuous ketone monitoring technology to better manage the risk of diabetic ketoacidosis (DKA). Current methods rely on patient-initiated testing, which experts argue is often delayed or forgotten, leading to preventable hospitalizations.
Why it matters
Improving monitoring technology could significantly reduce life-threatening complications for patients with type 1 diabetes.
As advances in diabetes management continue, two experts discuss what the new technology would mean for GPs and patients.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in